Shares of AMETEK, Inc. (NYSE:AME - Get Free Report) have been given a consensus rating of "Moderate Buy" by the thirteen analysts that are currently covering the company, Marketbeat reports. One analyst has rated the stock with a sell recommendation, five have given a hold recommendation, six have assigned a buy recommendation and one has given a strong buy recommendation to the company. The average 12-month price target among analysts that have issued ratings on the stock in the last year is $197.30.
A number of brokerages have recently commented on AME. Royal Bank Of Canada upped their price target on AMETEK from $194.00 to $201.00 and gave the company an "outperform" rating in a research report on Friday, May 2nd. Melius Research upgraded AMETEK to a "hold" rating in a research note on Monday, July 14th. Melius lowered AMETEK from a "buy" rating to a "hold" rating and set a $192.00 target price on the stock. in a research note on Monday, July 14th. Robert W. Baird decreased their target price on AMETEK from $197.00 to $190.00 and set a "neutral" rating on the stock in a research note on Wednesday, May 7th. Finally, Truist Financial upped their target price on AMETEK from $196.00 to $200.00 and gave the stock a "buy" rating in a research note on Monday, May 5th.
View Our Latest Stock Report on AMETEK
AMETEK Stock Up 1.1%
Shares of NYSE:AME traded up $1.94 during mid-day trading on Friday, hitting $181.14. 751,275 shares of the company traded hands, compared to its average volume of 1,312,555. The stock has a market cap of $41.82 billion, a P/E ratio of 29.65, a P/E/G ratio of 2.69 and a beta of 1.09. The company has a current ratio of 1.41, a quick ratio of 0.86 and a debt-to-equity ratio of 0.15. AMETEK has a 12-month low of $145.02 and a 12-month high of $198.33. The stock has a 50-day moving average price of $179.41 and a two-hundred day moving average price of $176.91.
AMETEK (NYSE:AME - Get Free Report) last posted its quarterly earnings data on Thursday, May 1st. The technology company reported $1.75 earnings per share for the quarter, topping the consensus estimate of $1.69 by $0.06. AMETEK had a return on equity of 16.75% and a net margin of 20.43%. The business had revenue of $1.73 billion for the quarter, compared to analysts' expectations of $1.74 billion. During the same quarter in the previous year, the firm earned $1.64 earnings per share. The business's revenue was down .2% on a year-over-year basis. On average, equities research analysts forecast that AMETEK will post 7.15 earnings per share for the current year.
AMETEK Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Monday, June 30th. Shareholders of record on Friday, June 13th were issued a $0.31 dividend. This represents a $1.24 annualized dividend and a yield of 0.68%. The ex-dividend date of this dividend was Friday, June 13th. AMETEK's dividend payout ratio (DPR) is currently 20.29%.
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently added to or reduced their stakes in AME. Norges Bank bought a new stake in shares of AMETEK in the fourth quarter worth about $697,080,000. Capital World Investors increased its holdings in shares of AMETEK by 70.0% in the fourth quarter. Capital World Investors now owns 5,760,017 shares of the technology company's stock worth $1,038,301,000 after purchasing an additional 2,371,062 shares during the last quarter. Invesco Ltd. increased its holdings in shares of AMETEK by 127.2% in the first quarter. Invesco Ltd. now owns 3,479,397 shares of the technology company's stock worth $598,943,000 after purchasing an additional 1,947,831 shares during the last quarter. Price T Rowe Associates Inc. MD increased its holdings in shares of AMETEK by 21.1% in the first quarter. Price T Rowe Associates Inc. MD now owns 10,970,047 shares of the technology company's stock worth $1,888,385,000 after purchasing an additional 1,908,742 shares during the last quarter. Finally, Lazard Asset Management LLC increased its holdings in shares of AMETEK by 393.1% in the fourth quarter. Lazard Asset Management LLC now owns 1,215,087 shares of the technology company's stock worth $219,030,000 after purchasing an additional 968,661 shares during the last quarter. Institutional investors own 87.43% of the company's stock.
AMETEK Company Profile
(
Get Free ReportAMETEK, Inc manufactures and sells electronic instruments and electromechanical devices in the North America, Europe, Asia, and South America, and internationally. The company's EIG segment offers advanced instruments for the process, aerospace, power, and industrial markets; process and analytical instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets; power quality monitoring and c devices, uninterruptible power supplies, programmable power and electromagnetic compatibility test equipment, and sensors for gas turbines and dashboard instruments; heavy trucks, instrumentation, and controls for the food and beverage industries; and aircraft and engine sensors, power supplies, embedded computing, monitoring, fuel and fluid measurement, and data acquisition systems for aerospace and defense industry.
Featured Articles

Before you consider AMETEK, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AMETEK wasn't on the list.
While AMETEK currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.